Back to Journals » Biologics: Targets and Therapy » Volume 3

Review

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

       
Total article views   HTML views PDF downloads Totals
14,501 Dovepress* 14,501+ 2,591 17,092
Totals 14,501 2,591 17,092
*Since 17 June 2009
+Since July 2016

View citations on Google Scholar